Summary

The global Protein Therapeutics Drugs market size was US$ 335700 million in 2025 and is forecast to reach a readjusted size of US$ 545990 million by 2032 with a CAGR of 7.3% during the forecast period 2026-2032.
Protein Therapeutics Drugs are a type of medicine that are used to treat a variety of diseases such as cancer, metabolic, immunological, hematological, hormonal, genetic, infectious diseases, and others. These drugs have the potential to significantly improve human health. In principle, protein therapy is similar to gene therapy; which involves protein delivery in specific amounts to the body to facilitate precise functioning of different glands and other organs in the body
Growth of the protein therapeutics market is majorly driven by rise in prevalence of chronic diseases and development of plasma-derived therapies. Increase in prevalence of various diseases such as cancer, metabolic disorders, genetic disorders, and immunological diseases are expected to propel demand for protein therapeutics. In addition, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, and cancer cases are expected to increase significantly in the future. Thus, rise in prevalence of cancer is anticipated to drive the protein therapeutics market.
The global Protein Therapeutics Drugs market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Johnson and Johnson
Pfizer Inc
F. Hoffmann La Roche Ltd
Novo Nordisk AS
Sanofi
Amgen Inc
Merck and Co., Inc
Abbott Laboratories
Baxter International Inc
Eli Lilly And Company
AbbVie
Novartis
Gilead Sciences
Bristol-Myers Squibb
Innovent
AstraZeneca
Hengrui Medicine
Takeda
Kanghong Pharma
Seagen
Sobi
Segment by Type
Monoclonal Antibodies
Insulin
Fusion Protein
Erythropoietin
Interferon
Human Growth Hormone
Others
Segment by Application
Cancer
Metabolic Disorders
Immunologic Disorders
Hematological Disorders
Hormonal Disorders
Genetic Disorders
Others
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Protein Therapeutics Drugs sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Protein Therapeutics Drugs manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Protein Therapeutics Drugs product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Protein Therapeutics Drugs value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Protein Therapeutics Drugs Product Scope
1.2 Protein Therapeutics Drugs by Type
1.2.1 Global Protein Therapeutics Drugs Sales by Type (2021, 2025 & 2032)
1.2.2 Monoclonal Antibodies
1.2.3 Insulin
1.2.4 Fusion Protein
1.2.5 Erythropoietin
1.2.6 Interferon
1.2.7 Human Growth Hormone
1.2.8 Others
1.3 Protein Therapeutics Drugs by Application
1.3.1 Global Protein Therapeutics Drugs Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Immunologic Disorders
1.3.5 Hematological Disorders
1.3.6 Hormonal Disorders
1.3.7 Genetic Disorders
1.3.8 Others
1.4 Global Protein Therapeutics Drugs Market Estimates and Forecasts (2021-2032)
1.4.1 Global Protein Therapeutics Drugs Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Protein Therapeutics Drugs Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Protein Therapeutics Drugs Price Trends (2021-2032)
1.5 Assumptions and Limitations

2 Market Size and Prospects by Region
2.1 Global Protein Therapeutics Drugs Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Protein Therapeutics Drugs Historical Market Scenario by Region (2021-2026)
2.2.1 Global Protein Therapeutics Drugs Sales Market Share by Region (2021-2026)
2.2.2 Global Protein Therapeutics Drugs Revenue Market Share by Region (2021-2026)
2.3 Global Protein Therapeutics Drugs Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Protein Therapeutics Drugs Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Protein Therapeutics Drugs Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Protein Therapeutics Drugs Market Size and Prospects (2021-2032)
2.4.2 Europe Protein Therapeutics Drugs Market Size and Prospects (2021-2032)
2.4.3 China Protein Therapeutics Drugs Market Size and Prospects (2021-2032)
2.4.4 Japan Protein Therapeutics Drugs Market Size and Prospects (2021-2032)

3 Global Market Size by Type
3.1 Global Protein Therapeutics Drugs Historical Market Review by Type (2021-2026)
3.1.1 Global Protein Therapeutics Drugs Sales by Type (2021-2026)
3.1.2 Global Protein Therapeutics Drugs Revenue by Type (2021-2026)
3.1.3 Global Protein Therapeutics Drugs Average Price by Type (2021-2026)
3.2 Global Protein Therapeutics Drugs Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Protein Therapeutics Drugs Sales Forecast by Type (2027-2032)
3.2.2 Global Protein Therapeutics Drugs Revenue Forecast by Type (2027-2032)
3.2.3 Global Protein Therapeutics Drugs Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Protein Therapeutics Drugs

4 Global Market Size by Application
4.1 Global Protein Therapeutics Drugs Historical Market Review by Application (2021-2026)
4.1.1 Global Protein Therapeutics Drugs Sales by Application (2021-2026)
4.1.2 Global Protein Therapeutics Drugs Revenue by Application (2021-2026)
4.1.3 Global Protein Therapeutics Drugs Average Price by Application (2021-2026)
4.2 Global Protein Therapeutics Drugs Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Protein Therapeutics Drugs Sales Forecast by Application (2027-2032)
4.2.2 Global Protein Therapeutics Drugs Revenue Forecast by Application (2027-2032)
4.2.3 Global Protein Therapeutics Drugs Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Protein Therapeutics Drugs Applications

5 Competition Landscape by Players
5.1 Global Protein Therapeutics Drugs Sales by Player (2021-2026)
5.2 Global Top Protein Therapeutics Drugs Players by Revenue (2021-2026)
5.3 Global Protein Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Protein Therapeutics Drugs revenue as of 2025
5.4 Global Protein Therapeutics Drugs Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Protein Therapeutics Drugs, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Protein Therapeutics Drugs, Product Type & Application
5.7 Global Key Manufacturers of Protein Therapeutics Drugs, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Protein Therapeutics Drugs Sales by Company
6.1.1.1 North America Protein Therapeutics Drugs Sales by Company (2021-2026)
6.1.1.2 North America Protein Therapeutics Drugs Revenue by Company (2021-2026)
6.1.2 North America Protein Therapeutics Drugs Sales Breakdown by Type (2021-2026)
6.1.3 North America Protein Therapeutics Drugs Sales Breakdown by Application (2021-2026)
6.1.4 North America Protein Therapeutics Drugs Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Protein Therapeutics Drugs Sales by Company
6.2.1.1 Europe Protein Therapeutics Drugs Sales by Company (2021-2026)
6.2.1.2 Europe Protein Therapeutics Drugs Revenue by Company (2021-2026)
6.2.2 Europe Protein Therapeutics Drugs Sales Breakdown by Type (2021-2026)
6.2.3 Europe Protein Therapeutics Drugs Sales Breakdown by Application (2021-2026)
6.2.4 Europe Protein Therapeutics Drugs Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Protein Therapeutics Drugs Sales by Company
6.3.1.1 China Protein Therapeutics Drugs Sales by Company (2021-2026)
6.3.1.2 China Protein Therapeutics Drugs Revenue by Company (2021-2026)
6.3.2 China Protein Therapeutics Drugs Sales Breakdown by Type (2021-2026)
6.3.3 China Protein Therapeutics Drugs Sales Breakdown by Application (2021-2026)
6.3.4 China Protein Therapeutics Drugs Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Protein Therapeutics Drugs Sales by Company
6.4.1.1 Japan Protein Therapeutics Drugs Sales by Company (2021-2026)
6.4.1.2 Japan Protein Therapeutics Drugs Revenue by Company (2021-2026)
6.4.2 Japan Protein Therapeutics Drugs Sales Breakdown by Type (2021-2026)
6.4.3 Japan Protein Therapeutics Drugs Sales Breakdown by Application (2021-2026)
6.4.4 Japan Protein Therapeutics Drugs Major Customers
6.4.5 Japan Market Trends and Opportunities

7 Company Profiles and Key Figures
7.1 Johnson and Johnson
7.1.1 Johnson and Johnson Company Information
7.1.2 Johnson and Johnson Business Overview
7.1.3 Johnson and Johnson Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Johnson and Johnson Protein Therapeutics Drugs Products Offered
7.1.5 Johnson and Johnson Recent Development
7.2 Pfizer Inc
7.2.1 Pfizer Inc Company Information
7.2.2 Pfizer Inc Business Overview
7.2.3 Pfizer Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Pfizer Inc Protein Therapeutics Drugs Products Offered
7.2.5 Pfizer Inc Recent Development
7.3 F. Hoffmann La Roche Ltd
7.3.1 F. Hoffmann La Roche Ltd Company Information
7.3.2 F. Hoffmann La Roche Ltd Business Overview
7.3.3 F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.3.4 F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Products Offered
7.3.5 F. Hoffmann La Roche Ltd Recent Development
7.4 Novo Nordisk AS
7.4.1 Novo Nordisk AS Company Information
7.4.2 Novo Nordisk AS Business Overview
7.4.3 Novo Nordisk AS Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Novo Nordisk AS Protein Therapeutics Drugs Products Offered
7.4.5 Novo Nordisk AS Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Sanofi Protein Therapeutics Drugs Products Offered
7.5.5 Sanofi Recent Development
7.6 Amgen Inc
7.6.1 Amgen Inc Company Information
7.6.2 Amgen Inc Business Overview
7.6.3 Amgen Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Amgen Inc Protein Therapeutics Drugs Products Offered
7.6.5 Amgen Inc Recent Development
7.7 Merck and Co., Inc
7.7.1 Merck and Co., Inc Company Information
7.7.2 Merck and Co., Inc Business Overview
7.7.3 Merck and Co., Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Merck and Co., Inc Protein Therapeutics Drugs Products Offered
7.7.5 Merck and Co., Inc Recent Development
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Information
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Abbott Laboratories Protein Therapeutics Drugs Products Offered
7.8.5 Abbott Laboratories Recent Development
7.9 Baxter International Inc
7.9.1 Baxter International Inc Company Information
7.9.2 Baxter International Inc Business Overview
7.9.3 Baxter International Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Baxter International Inc Protein Therapeutics Drugs Products Offered
7.9.5 Baxter International Inc Recent Development
7.10 Eli Lilly And Company
7.10.1 Eli Lilly And Company Company Information
7.10.2 Eli Lilly And Company Business Overview
7.10.3 Eli Lilly And Company Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Eli Lilly And Company Protein Therapeutics Drugs Products Offered
7.10.5 Eli Lilly And Company Recent Development
7.11 AbbVie
7.11.1 AbbVie Company Information
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.11.4 AbbVie Protein Therapeutics Drugs Products Offered
7.11.5 AbbVie Recent Development
7.12 Novartis
7.12.1 Novartis Company Information
7.12.2 Novartis Business Overview
7.12.3 Novartis Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Novartis Protein Therapeutics Drugs Products Offered
7.12.5 Novartis Recent Development
7.13 Gilead Sciences
7.13.1 Gilead Sciences Company Information
7.13.2 Gilead Sciences Business Overview
7.13.3 Gilead Sciences Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Gilead Sciences Protein Therapeutics Drugs Products Offered
7.13.5 Gilead Sciences Recent Development
7.14 Bristol-Myers Squibb
7.14.1 Bristol-Myers Squibb Company Information
7.14.2 Bristol-Myers Squibb Business Overview
7.14.3 Bristol-Myers Squibb Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Bristol-Myers Squibb Protein Therapeutics Drugs Products Offered
7.14.5 Bristol-Myers Squibb Recent Development
7.15 Innovent
7.15.1 Innovent Company Information
7.15.2 Innovent Business Overview
7.15.3 Innovent Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Innovent Protein Therapeutics Drugs Products Offered
7.15.5 Innovent Recent Development
7.16 AstraZeneca
7.16.1 AstraZeneca Company Information
7.16.2 AstraZeneca Business Overview
7.16.3 AstraZeneca Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.16.4 AstraZeneca Protein Therapeutics Drugs Products Offered
7.16.5 AstraZeneca Recent Development
7.17 Hengrui Medicine
7.17.1 Hengrui Medicine Company Information
7.17.2 Hengrui Medicine Business Overview
7.17.3 Hengrui Medicine Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Hengrui Medicine Protein Therapeutics Drugs Products Offered
7.17.5 Hengrui Medicine Recent Development
7.18 Takeda
7.18.1 Takeda Company Information
7.18.2 Takeda Business Overview
7.18.3 Takeda Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.18.4 Takeda Protein Therapeutics Drugs Products Offered
7.18.5 Takeda Recent Development
7.19 Kanghong Pharma
7.19.1 Kanghong Pharma Company Information
7.19.2 Kanghong Pharma Business Overview
7.19.3 Kanghong Pharma Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.19.4 Kanghong Pharma Protein Therapeutics Drugs Products Offered
7.19.5 Kanghong Pharma Recent Development
7.20 Seagen
7.20.1 Seagen Company Information
7.20.2 Seagen Business Overview
7.20.3 Seagen Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.20.4 Seagen Protein Therapeutics Drugs Products Offered
7.20.5 Seagen Recent Development
7.21 Sobi
7.21.1 Sobi Company Information
7.21.2 Sobi Business Overview
7.21.3 Sobi Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
7.21.4 Sobi Protein Therapeutics Drugs Products Offered
7.21.5 Sobi Recent Development

8 Protein Therapeutics Drugs Manufacturing Cost Analysis
8.1 Protein Therapeutics Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Protein Therapeutics Drugs
8.4 Protein Therapeutics Drugs Industrial Chain Analysis

9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Protein Therapeutics Drugs Distributors List
9.3 Protein Therapeutics Drugs Customers

10 Protein Therapeutics Drugs Market Dynamics
10.1 Protein Therapeutics Drugs Industry Trends
10.2 Protein Therapeutics Drugs Market Drivers
10.3 Protein Therapeutics Drugs Market Challenges
10.4 Protein Therapeutics Drugs Market Restraints

11 Research Findings and Conclusion

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Protein Therapeutics Drugs Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Protein Therapeutics Drugs Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Protein Therapeutics Drugs Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Protein Therapeutics Drugs Sales (K Dose) by Region (2021-2026)
Table 5. Global Protein Therapeutics Drugs Sales Market Share by Region (2021-2026)
Table 6. Global Protein Therapeutics Drugs Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Protein Therapeutics Drugs Revenue Share by Region (2021-2026)
Table 8. Global Protein Therapeutics Drugs Sales (K Dose) Forecast by Region (2027-2032)
Table 9. Global Protein Therapeutics Drugs Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Protein Therapeutics Drugs Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Protein Therapeutics Drugs Revenue Share Forecast by Region (2027-2032)
Table 12. Global Protein Therapeutics Drugs Sales by Type (K Dose) & (2021-2026)
Table 13. Global Protein Therapeutics Drugs Sales Share by Type (2021-2026)
Table 14. Global Protein Therapeutics Drugs Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Protein Therapeutics Drugs Average Price by Type (US$/Dose) & (2021-2026)
Table 16. Global Protein Therapeutics Drugs Sales by Type (K Dose) & (2027-2032)
Table 17. Global Protein Therapeutics Drugs Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Protein Therapeutics Drugs Average Price by Type (US$/Dose) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Protein Therapeutics Drugs Sales by Application (K Dose) & (2021-2026)
Table 21. Global Protein Therapeutics Drugs Sales Share by Application (2021-2026)
Table 22. Global Protein Therapeutics Drugs Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Protein Therapeutics Drugs Average Price by Application (US$/Dose) & (2021-2026)
Table 24. Global Protein Therapeutics Drugs Sales by Application (K Dose) & (2027-2032)
Table 25. Global Protein Therapeutics Drugs Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Protein Therapeutics Drugs Average Price by Application (US$/Dose) & (2027-2032)
Table 27. New Sources of Growth in Protein Therapeutics Drugs Applications
Table 28. Global Protein Therapeutics Drugs Sales by Company (K Dose) & (2021-2026)
Table 29. Global Protein Therapeutics Drugs Sales Share by Company (2021-2026)
Table 30. Global Protein Therapeutics Drugs Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Protein Therapeutics Drugs Revenue Share by Company (2021-2026)
Table 32. Global Protein Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Therapeutics Drugs as of 2025)
Table 33. Global Market Protein Therapeutics Drugs Average Price by Company (US$/Dose) & (2021-2026)
Table 34. Global Key Manufacturers of Protein Therapeutics Drugs, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Protein Therapeutics Drugs, Product Type & Application
Table 36. Global Key Manufacturers of Protein Therapeutics Drugs, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Protein Therapeutics Drugs Sales by Company (2021-2026) & (K Dose)
Table 39. North America Protein Therapeutics Drugs Sales Market Share by Company (2021-2026)
Table 40. North America Protein Therapeutics Drugs Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Protein Therapeutics Drugs Revenue Market Share by Company (2021-2026)
Table 42. North America Protein Therapeutics Drugs Sales by Type (2021-2026) & (K Dose)
Table 43. North America Protein Therapeutics Drugs Sales Market Share by Type (2021-2026)
Table 44. North America Protein Therapeutics Drugs Sales by Application (2021-2026) & (K Dose)
Table 45. North America Protein Therapeutics Drugs Sales Market Share by Application (2021-2026)
Table 46. Europe Protein Therapeutics Drugs Sales by Company (2021-2026) & (K Dose)
Table 47. Europe Protein Therapeutics Drugs Sales Market Share by Company (2021-2026)
Table 48. Europe Protein Therapeutics Drugs Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Protein Therapeutics Drugs Revenue Market Share by Company (2021-2026)
Table 50. Europe Protein Therapeutics Drugs Sales by Type (2021-2026) & (K Dose)
Table 51. Europe Protein Therapeutics Drugs Sales Market Share by Type (2021-2026)
Table 52. Europe Protein Therapeutics Drugs Sales by Application (2021-2026) & (K Dose)
Table 53. Europe Protein Therapeutics Drugs Sales Market Share by Application (2021-2026)
Table 54. China Protein Therapeutics Drugs Sales by Company (2021-2026) & (K Dose)
Table 55. China Protein Therapeutics Drugs Sales Market Share by Company (2021-2026)
Table 56. China Protein Therapeutics Drugs Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Protein Therapeutics Drugs Revenue Market Share by Company (2021-2026)
Table 58. China Protein Therapeutics Drugs Sales by Type (2021-2026) & (K Dose)
Table 59. China Protein Therapeutics Drugs Sales Market Share by Type (2021-2026)
Table 60. China Protein Therapeutics Drugs Sales by Application (2021-2026) & (K Dose)
Table 61. China Protein Therapeutics Drugs Sales Market Share by Application (2021-2026)
Table 62. Japan Protein Therapeutics Drugs Sales by Company (2021-2026) & (K Dose)
Table 63. Japan Protein Therapeutics Drugs Sales Market Share by Company (2021-2026)
Table 64. Japan Protein Therapeutics Drugs Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Protein Therapeutics Drugs Revenue Market Share by Company (2021-2026)
Table 66. Japan Protein Therapeutics Drugs Sales by Type (2021-2026) & (K Dose)
Table 67. Japan Protein Therapeutics Drugs Sales Market Share by Type (2021-2026)
Table 68. Japan Protein Therapeutics Drugs Sales by Application (2021-2026) & (K Dose)
Table 69. Japan Protein Therapeutics Drugs Sales Market Share by Application (2021-2026)
Table 70. Johnson and Johnson Company Information
Table 71. Johnson and Johnson Description and Business Overview
Table 72. Johnson and Johnson Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 73. Johnson and Johnson Protein Therapeutics Drugs Product
Table 74. Johnson and Johnson Recent Development
Table 75. Pfizer Inc Company Information
Table 76. Pfizer Inc Description and Business Overview
Table 77. Pfizer Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 78. Pfizer Inc Protein Therapeutics Drugs Product
Table 79. Pfizer Inc Recent Development
Table 80. F. Hoffmann La Roche Ltd Company Information
Table 81. F. Hoffmann La Roche Ltd Description and Business Overview
Table 82. F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 83. F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Product
Table 84. F. Hoffmann La Roche Ltd Recent Development
Table 85. Novo Nordisk AS Company Information
Table 86. Novo Nordisk AS Description and Business Overview
Table 87. Novo Nordisk AS Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 88. Novo Nordisk AS Protein Therapeutics Drugs Product
Table 89. Novo Nordisk AS Recent Development
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 93. Sanofi Protein Therapeutics Drugs Product
Table 94. Sanofi Recent Development
Table 95. Amgen Inc Company Information
Table 96. Amgen Inc Description and Business Overview
Table 97. Amgen Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 98. Amgen Inc Protein Therapeutics Drugs Product
Table 99. Amgen Inc Recent Development
Table 100. Merck and Co., Inc Company Information
Table 101. Merck and Co., Inc Description and Business Overview
Table 102. Merck and Co., Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 103. Merck and Co., Inc Protein Therapeutics Drugs Product
Table 104. Merck and Co., Inc Recent Development
Table 105. Abbott Laboratories Company Information
Table 106. Abbott Laboratories Description and Business Overview
Table 107. Abbott Laboratories Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 108. Abbott Laboratories Protein Therapeutics Drugs Product
Table 109. Abbott Laboratories Recent Development
Table 110. Baxter International Inc Company Information
Table 111. Baxter International Inc Description and Business Overview
Table 112. Baxter International Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 113. Baxter International Inc Protein Therapeutics Drugs Product
Table 114. Baxter International Inc Recent Development
Table 115. Eli Lilly And Company Company Information
Table 116. Eli Lilly And Company Description and Business Overview
Table 117. Eli Lilly And Company Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 118. Eli Lilly And Company Protein Therapeutics Drugs Product
Table 119. Eli Lilly And Company Recent Development
Table 120. AbbVie Company Information
Table 121. AbbVie Description and Business Overview
Table 122. AbbVie Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 123. AbbVie Protein Therapeutics Drugs Product
Table 124. AbbVie Recent Development
Table 125. Novartis Company Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 128. Novartis Protein Therapeutics Drugs Product
Table 129. Novartis Recent Development
Table 130. Gilead Sciences Company Information
Table 131. Gilead Sciences Description and Business Overview
Table 132. Gilead Sciences Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 133. Gilead Sciences Protein Therapeutics Drugs Product
Table 134. Gilead Sciences Recent Development
Table 135. Bristol-Myers Squibb Company Information
Table 136. Bristol-Myers Squibb Description and Business Overview
Table 137. Bristol-Myers Squibb Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 138. Bristol-Myers Squibb Protein Therapeutics Drugs Product
Table 139. Bristol-Myers Squibb Recent Development
Table 140. Innovent Company Information
Table 141. Innovent Description and Business Overview
Table 142. Innovent Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 143. Innovent Protein Therapeutics Drugs Product
Table 144. Innovent Recent Development
Table 145. AstraZeneca Company Information
Table 146. AstraZeneca Description and Business Overview
Table 147. AstraZeneca Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 148. AstraZeneca Protein Therapeutics Drugs Product
Table 149. AstraZeneca Recent Development
Table 150. Hengrui Medicine Company Information
Table 151. Hengrui Medicine Description and Business Overview
Table 152. Hengrui Medicine Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 153. Hengrui Medicine Protein Therapeutics Drugs Product
Table 154. Hengrui Medicine Recent Development
Table 155. Takeda Company Information
Table 156. Takeda Description and Business Overview
Table 157. Takeda Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 158. Takeda Protein Therapeutics Drugs Product
Table 159. Takeda Recent Development
Table 160. Kanghong Pharma Company Information
Table 161. Kanghong Pharma Description and Business Overview
Table 162. Kanghong Pharma Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 163. Kanghong Pharma Protein Therapeutics Drugs Product
Table 164. Kanghong Pharma Recent Development
Table 165. Seagen Company Information
Table 166. Seagen Description and Business Overview
Table 167. Seagen Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 168. Seagen Protein Therapeutics Drugs Product
Table 169. Seagen Recent Development
Table 170. Sobi Company Information
Table 171. Sobi Description and Business Overview
Table 172. Sobi Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 173. Sobi Protein Therapeutics Drugs Product
Table 174. Sobi Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Protein Therapeutics Drugs Distributors List
Table 178. Protein Therapeutics Drugs Customers List
Table 179. Protein Therapeutics Drugs Market Trends
Table 180. Protein Therapeutics Drugs Market Drivers
Table 181. Protein Therapeutics Drugs Market Challenges
Table 182. Protein Therapeutics Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources

List of Figures
Figure 1. Protein Therapeutics Drugs Product Picture
Figure 2. Global Protein Therapeutics Drugs Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Protein Therapeutics Drugs Sales Market Share by Type in 2025 & 2032
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Insulin Product Picture
Figure 6. Fusion Protein Product Picture
Figure 7. Erythropoietin Product Picture
Figure 8. Interferon Product Picture
Figure 9. Human Growth Hormone Product Picture
Figure 10. Others Product Picture
Figure 11. Global Protein Therapeutics Drugs Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 12. Global Protein Therapeutics Drugs Sales Market Share by Application in 2025 & 2032
Figure 13. Cancer Examples
Figure 14. Metabolic Disorders Examples
Figure 15. Immunologic Disorders Examples
Figure 16. Hematological Disorders Examples
Figure 17. Hormonal Disorders Examples
Figure 18. Genetic Disorders Examples
Figure 19. Others Examples
Figure 20. Global Protein Therapeutics Drugs Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 21. Global Protein Therapeutics Drugs Sales Growth Rate (2021-2032) & (US$ Million)
Figure 22. Global Protein Therapeutics Drugs Sales (K Dose) Growth Rate (2021-2032)
Figure 23. Global Protein Therapeutics Drugs Price Trends Growth Rate (2021-2032) & (US$/Dose)
Figure 24. Protein Therapeutics Drugs Report Years Considered
Figure 25. Global Market Protein Therapeutics Drugs Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 26. Global Protein Therapeutics Drugs Revenue Market Share by Region: 2021 VS 2025
Figure 27. North America Protein Therapeutics Drugs Revenue (US$ Million) Growth Rate (2021-2032)
Figure 28. North America Protein Therapeutics Drugs Sales (K Dose) Growth Rate (2021-2032)
Figure 29. Europe Protein Therapeutics Drugs Revenue (US$ Million) Growth Rate (2021-2032)
Figure 30. Europe Protein Therapeutics Drugs Sales (K Dose) Growth Rate (2021-2032)
Figure 31. China Protein Therapeutics Drugs Revenue (US$ Million) Growth Rate (2021-2032)
Figure 32. China Protein Therapeutics Drugs Sales (K Dose) Growth Rate (2021-2032)
Figure 33. Japan Protein Therapeutics Drugs Revenue (US$ Million) Growth Rate (2021-2032)
Figure 34. Japan Protein Therapeutics Drugs Sales (K Dose) Growth Rate (2021-2032)
Figure 35. Global Protein Therapeutics Drugs Revenue Share by Type (2021-2026)
Figure 36. Global Protein Therapeutics Drugs Sales Share by Type (2027-2032)
Figure 37. Global Protein Therapeutics Drugs Revenue Share by Type (2027-2032)
Figure 38. Global Protein Therapeutics Drugs Revenue Share by Application (2021-2026)
Figure 39. Global Protein Therapeutics Drugs Revenue Market Share by Application in 2021 & 2025
Figure 40. Global Protein Therapeutics Drugs Sales Share by Application (2027-2032)
Figure 41. Global Protein Therapeutics Drugs Revenue Share by Application (2027-2032)
Figure 42. Global Protein Therapeutics Drugs Sales Share by Company (2025)
Figure 43. Global Protein Therapeutics Drugs Revenue Share by Company (2025)
Figure 44. Global 5 Largest Protein Therapeutics Drugs Players Market Share by Revenue in Protein Therapeutics Drugs: 2021 & 2025
Figure 45. Protein Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 46. Manufacturing Cost Structure of Protein Therapeutics Drugs
Figure 47. Manufacturing Process Analysis of Protein Therapeutics Drugs
Figure 48. Protein Therapeutics Drugs Industrial Chain
Figure 49. Channels of Distribution (Direct Vs Distribution)
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed